Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Sickle Cell Disease is a complex and debilitating ... It is caused by a mutation in the HBB gene, which leads to the production of abnormal haemoglobin known as haemoglobin S.

Zynext Ventures is investing in Illexcor Therapeutics to advance the clinical development of ILX002, its lead candidate for ...

Sebastien Beauzile became the first person in NY to be made symptom-free after undergoing a new type of gene therapy.

Research from UAB published in the New England Journal of Medicine in February 2022 suggests a gene therapy called LentiGlobin could provide a drastic improvement in quality of life for people with ...

A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...

The influential Institute for Clinical and Economic Review (ICER) in the US has issued draft guidance suggesting that new gene therapies for sickle cell disease (SCD) from Vertex Pharma and ...

A Fayetteville teen is making history in North Carolina after undergoing a new gene therapy for sickle cell disease. Aaron Scott was diagnosed with sickle cell at birth. Sickle cell is a genetic ...

21-year-old Sebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell anemia using the innovative Lyfgenia gene therapy. This ...